Acetl Tetrapeptide-15 | CAS:NO17

We serve Acetl Tetrapeptide-15 CAS:NO17 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Acetl Tetrapeptide-15

Chemical Name:Acetl Tetrapeptide-15
CAS.NO:NA
Synonyms:Acetl Tetrapeptide-15
N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 1055.3±65.0 °C at 760 mmHg
Molecular Formula C34H39N5O6
Molecular Weight 613.703
Flash Point 592.0±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.617
 
Specification:
Appearance:White powder
Assay:≥95%
Moisture:≤5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Acetyl tetrapeptide-15 is tetrapeptide that is used in cosmetics and skincare formulas. This ingredient targets neurosensitive skin by decreasing the release of pro-inflammatory mediators and increasing the skin’s sensitivity tolerance threshold, making skin less reactive and diminishing sensations of pain and discomfort.



Contact us for information like Acetl Tetrapeptide-15 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide Use and application,N-Acetyl-L-tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide technical grade,usp/ep/jp grade.


Related News: The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.5-Fluoronicotinic acid manufacturer At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.(2S,4R)-Methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride supplier The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.10-bromobenzo[b]naphtho[1,2-d]furan vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.